Skip to main content
OpenTrials

Clinical trial condition

Non-Alcoholic Fatty Liver Disease

Explore clinical trials studying Non-Alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.

326 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Non-Alcoholic Fatty Liver Disease trial results

Completed

Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis

NCT03061721

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations
  • Precision Research Chula Vista, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Catalina Research Institute Montclair, California, United States
  • California liver research institute Pasadena, California, United States
View all 18 locations
View Trial Details
Completed

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

NCT04216589

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +16 more
Locations
  • Alabama CRS (Site ID: 31788) Birmingham, Alabama, United States
  • University of Colorado Hospital CRS (Site ID: 6101) Aurora, Colorado, United States
  • Johns Hopkins University CRS Baltimore, Maryland, United States
  • Massachusetts General Hospital CRS (MGH CRS) (Site ID: 101) Boston, Massachusetts, United States
View Trial Details

Related conditions